Skip Main Navigation Links Jump to Footer
Nature Reviews EndocrinologyVolume 7, Issue 1, January 2011, Pages 9-10

Cancer: Small papillary thyroid cancers-is BRAF of prognostic value?(Note)

  • Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Roberto Frias s/n, 4200-465 Porto, Portugal

Abstract

[No abstract available]

Indexed keywords

EMTREE drug terms:B Raf kinase
EMTREE medical terms:cancer incidencecancer sizegene mutationhumanlymph node metastasisnotepatient carepriority journalprognosisrisk assessmentthyroid papillary carcinoma
MeSH:Carcinoma, PapillaryHumansProto-Oncogene Proteins B-rafThyroid Neoplasms

Chemicals and CAS Registry Numbers:

BRAF protein, human, 2.7.1.37; Proto-Oncogene Proteins B-raf, 2.7.11.1

  • ISSN: 17595029
  • Source Type: Journal
  • Original language: English
  • DOI: 10.1038/nrendo.2010.213
  • PubMed ID: 21160471
  • Document Type: Note

  Sobrinho-Simões, M.; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Roberto Frias s/n, Portugal;
© Copyright 2011 Elsevier B.V., All rights reserved. © MEDLINE® is the source for the MeSH terms of this document.

Cited by 14 documents

Tallini, G. , De Biase, D. , Durante, C.
BRAF V600E and risk stratification of thyroid microcarcinoma: A multicenter pathological and clinical study
(2015) Modern Pathology
Carneiro, R.M. , Carneiro, B.A. , Agulnik, M.
Targeted therapies in advanced differentiated thyroid cancer
(2015) Cancer Treatment Reviews
Jasim, S. , Ozsari, L. , Habra, M.A.
Multikinase inhibitors use in differentiated thyroid carcinoma
(2014) Biologics: Targets and Therapy
View details of all 14 citations
{"topic":{"name":"Thyroid Neoplasms; Carcinoma, Papillary; RAS mutations","id":3209,"uri":"Topic/3209","prominencePercentile":97.846756,"prominencePercentileString":"97.847","overallScholarlyOutput":0},"dig":"68ac9dac4bbc3dae5224d16f2c9fe89b946704c20522d8dc04862203c985a1bb"}

SciVal Topic Prominence

Topic:
Prominence percentile: